Company / SG&A per Share
Mineralys Therapeutics, Inc. SG&A per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.49
FY2024
5-year range
$0.40 / $1.01
FY2022-FY2024
Trend
+24.2%
vs FY2023
Sector context
#168 of 210
Health Care
What the data says
Mineralys Therapeutics, Inc.'s sg&a per share of $0.49 is lower than 80% of companies in the Health Care sector (FY2024). Improved from $1.01 to $0.49 over the past 2 years.
Based on SEC 10-K filings.
0.49 in FY2024.
Improved from $1.01 to $0.49 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 210This company $0.49 Sector average $40.75
▼
-98.8% below sector average
Key checks
Key Insights
- In FY2024, sg&a per share increased 24.2% year-over-year.
- Ranks #168 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.49 | +24.2% |
| FY2023 | $0.40 | -61.0% |
| FY2022 | $1.01 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026